• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Director Burdiek Michael J bought $21,450 worth of shares (15,000 units at $1.43), increasing direct ownership by 2% to 631,560 units (SEC Form 4)

    5/15/25 5:05:47 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care
    Get the next $DCGO alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Burdiek Michael J

    (Last) (First) (Middle)
    C/O DOCGO INC.
    685 THIRD AVENUE, 9TH FLOOR

    (Street)
    NEW YORK NY 10017

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    DocGo Inc. [ DCGO ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    05/15/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 05/15/2025 P 15,000 A $1.43 631,560(1) D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. This amount reflects 34,965 restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan") that will vest on December 13, 2025, subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.
    Remarks:
    /s/ Jerilyn Laskie, as Attorney-in-Fact for Michael J. Burdiek 05/15/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $DCGO alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DCGO

    DatePrice TargetRatingAnalyst
    5/9/2025Buy → Neutral
    BTIG Research
    2/28/2025$5.00 → $2.85Buy → Hold
    Deutsche Bank
    8/18/2023$15.00Buy
    BTIG Research
    4/21/2023$11.00Overweight
    Cantor Fitzgerald
    4/19/2022$11.00Buy
    Deutsche Bank
    1/19/2022$14.00Buy
    Stifel
    12/21/2021$13.00Buy
    Canaccord Genuity
    12/7/2021$14.00Buy
    Needham
    More analyst ratings

    $DCGO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    DocGo Announces Participation at Three Upcoming Conferences

    DocGo Inc. (NASDAQ:DCGO) ("DocGo"), a leading provider of technology-enabled mobile health and medical transportation services, announced today that management will be participating in the following investor conferences in August and September: Three Part Advisors Midwest (August 26th) Norm Rosenberg, Chief Financial Officer will participate in 1x1 meetings, and deliver a presentation on Tuesday August 26th at 11:30 AM CT. A webcast of the event will be available on the investor relations section of DocGo's website at https://ir.docgo.com/. Cantor Global Healthcare Conference (September 3rd) Lee Bienstock, Chief Executive Officer will hold 1x1 meetings, and participate in a fireside cha

    8/18/25 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo Announces Second Quarter 2025 Results

    Company Reiterates 2025 Revenue and Adjusted EBITDA Guidance, Increases Total Cash Balance to $128.7 Million, Signs New Contracts Across All Business Verticals Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights Total revenue for the second quarter of 2025 was $80.4 million, compared to $164.9 million in the second quarter of 2024. This decline was due to the planned wind-down of migrant-rel

    8/7/25 4:05:00 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo to Provide Digital Transportation Management Platform, Dedicated Ambulance Service to Major New York Health System

    DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced a new contract with one of the largest academic medical systems in the New York metro area. Through this contract, DocGo's dispatchers located within the health system's discharge management office will use DocGo's proprietary transportation management software for centralized management of all discharges across the health system. Through its Ambulnz brand, DocGo will also provide dedicated basic life support (BLS) ambulance services at select facilities. "The consolidated, centralized transportation data offered by DocGo's soft

    8/6/25 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $DCGO
    SEC Filings

    View All

    DocGo Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - DocGo Inc. (0001822359) (Filer)

    8/7/25 4:47:57 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    SEC Form 10-Q filed by DocGo Inc.

    10-Q - DocGo Inc. (0001822359) (Filer)

    8/7/25 4:19:58 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - DocGo Inc. (0001822359) (Filer)

    6/18/25 4:21:01 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $DCGO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $DCGO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    DocGo downgraded by BTIG Research

    BTIG Research downgraded DocGo from Buy to Neutral

    5/9/25 8:41:42 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded DocGo from Buy to Hold and set a new price target of $2.85 from $5.00 previously

    2/28/25 8:51:46 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    BTIG Research initiated coverage on DocGo with a new price target

    BTIG Research initiated coverage of DocGo with a rating of Buy and set a new price target of $15.00

    8/18/23 7:24:03 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    Director Burdiek Michael J bought $13,300 worth of shares (10,000 units at $1.33), increasing direct ownership by 2% to 641,560 units (SEC Form 4)

    4 - DocGo Inc. (0001822359) (Issuer)

    5/23/25 4:25:30 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    Director Burdiek Michael J bought $21,450 worth of shares (15,000 units at $1.43), increasing direct ownership by 2% to 631,560 units (SEC Form 4)

    4 - DocGo Inc. (0001822359) (Issuer)

    5/15/25 5:05:47 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    Director Klasko Stephen K. M.D. bought $22,350 worth of shares (15,000 units at $1.49) (SEC Form 4)

    4 - DocGo Inc. (0001822359) (Issuer)

    5/14/25 5:42:40 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $DCGO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Compliance Officer Sugrue Stephen covered exercise/tax liability with 5,813 shares, decreasing direct ownership by 2% to 351,515 units (SEC Form 4)

    4 - DocGo Inc. (0001822359) (Issuer)

    7/2/25 4:34:23 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    CFO and Treasurer Rosenberg Norman covered exercise/tax liability with 11,332 shares, decreasing direct ownership by 1% to 859,940 units (SEC Form 4)

    4 - DocGo Inc. (0001822359) (Issuer)

    7/2/25 4:33:28 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    Chief Executive Officer Bienstock Lee covered exercise/tax liability with 18,597 shares, decreasing direct ownership by 0.95% to 1,936,917 units (SEC Form 4)

    4 - DocGo Inc. (0001822359) (Issuer)

    7/2/25 4:32:24 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $DCGO
    Leadership Updates

    Live Leadership Updates

    View All

    DocGo Acquires PTI Health To Expand Proactive Healthcare Offering with Mobile Lab Collection and Mobile Phlebotomy Services

    DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced the acquisition of PTI Health, a mid-Atlantic mobile lab collection and phlebotomy services company. This strategic move expands DocGo's healthcare service offering to include mobile phlebotomy lab services, addressing critical gaps in diagnostic care for underserved populations. With this acquisition, DocGo will facilitate timely, convenient blood collection and additional at-home testing services for patients, offering a new level of care to those with limited access to traditional labs or transportation options. The acquisition enhances DocGo's offerings

    2/10/25 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo Appoints Healthcare Visionary Dr. Stephen K. Klasko as Chair of the Board

    DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced the appointment of Stephen K. Klasko, M.D., M.B.A as the new independent, non-executive Chair of its Board of Directors, effective October 1, 2024. Dr. Klasko has an extensive background in leadership roles within healthcare, higher education and medical industry innovation, including an eight-year tenure as the President of Thomas Jefferson University and the CEO of Jefferson Health where he oversaw its expansion to 18 hospitals and over 35,000 employees. Prior to that, he was CEO of USF Health and Dean of the Morsani College of Medicine at the University o

    9/30/24 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo Appoints Eiwe Lingefors as New Chief Information Officer

    DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-driven healthcare solutions, is proud to announce Eiwe Lingefors as Chief Information Officer (CIO). Lingefors most recently served as the company's Chief Information Security Officer, and will continue in this role as well. In his new role as CIO, Lingefors will lead both DocGo's information security and digital innovation strategy in an evolving cybersecurity landscape. "Eiwe has been a vital part of our team, and his deep expertise in the security landscape has been instrumental in DocGo's operations," said Lee Bienstock, CEO of DocGo. "He has done an excellent job strengthening DocGo's existing cybers

    9/26/24 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $DCGO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by DocGo Inc.

    SC 13D/A - DocGo Inc. (0001822359) (Subject)

    11/29/24 4:14:57 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by DocGo Inc.

    SC 13G/A - DocGo Inc. (0001822359) (Subject)

    11/14/24 9:56:36 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by DocGo Inc. (Amendment)

    SC 13G/A - DocGo Inc. (0001822359) (Subject)

    3/1/24 4:53:15 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $DCGO
    Financials

    Live finance-specific insights

    View All

    DocGo Announces Second Quarter 2025 Results

    Company Reiterates 2025 Revenue and Adjusted EBITDA Guidance, Increases Total Cash Balance to $128.7 Million, Signs New Contracts Across All Business Verticals Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights Total revenue for the second quarter of 2025 was $80.4 million, compared to $164.9 million in the second quarter of 2024. This decline was due to the planned wind-down of migrant-rel

    8/7/25 4:05:00 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo to Announce Second Quarter 2025 Results on Thursday, August 7, 2025

    Management to host conference call and webcast at 5:00 p.m. ET on that day DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, announced today that the Company will release its financial results for the second quarter ended June 30, 2025 after the markets close on Thursday, August 7, 2025. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Thursday, August 7, 2025 5:00 p.m. ET 1-800-717-1738 (U.S.) 1-646-307-1865 (international) Conference ID: 75731 To access the Call me™ feature, which avoids the need to w

    7/24/25 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo Announces First Quarter 2025 Results

    Company Focuses on Growing Medical Transportation and Payer & Provider Businesses, Navigates Municipal Uncertainty and Migrant Services Transition Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the quarter ended March 31, 2025. Lee Bienstock, Chief Executive Officer of DocGo, commented, "The impact of ongoing policy changes in Washington and adjustments to public spending on healthcare-related projects have created substantial uncertainty in our Government Populati

    5/8/25 4:05:00 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care